Ultrasound Elastography in Fatty Liver Disease: A Noninvasive Assessment of Hepatic Fibrosis
Annals of African Medicine · 18.11.2026
DOI: 10.4103/aam.aam_526_26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of African Medicine, online erschienen am 18.11.2026. Verfasst von Parthvi Jaiswal und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Fatty liver disease, including nonalcoholic fatty liver disease (NAFLD), has become one of the most common chronic liver disorders worldwide because of the increasing prevalence of obesity, diabetes mellitus, dyslipidemia, and metabolic syndrome. Progressive hepatic fibrosis is the most important predictor of adverse outcomes, including cirrhosis and liver failure. Early diagnosis and staging of fibrosis are, therefore, essential for timely management. Although liver biopsy remains the reference standard, it is invasive, costly, and associated with potential complications. Ultrasound elastography has emerged as a reliable non-invasive imaging technique for assessment of liver stiffness and fibrosis.
Objective
To evaluate the role of ultrasound shear wave elastography in assessing hepatic fibrosis in patients with fatty liver disease. Materials and Methods: This time-limited observational cross-sectional study included 499 adult patients with ultrasonographical diagnosed fatty liver disease. Shear wave elastography was performed using a standardized protocol with measurements obtained from the right hepatic lobe through an intercostal approach. Three valid acquisitions were recorded for each patient, and average liver stiffness values were calculated in kilopascals. Fibrosis grading was categorized according to METAVIR-equivalent scores. Clinical variables such as age, sex, obesity, and diabetes were also analyzed.
Results
Liver stiffness values showed a progressive increase with worsening fibrosis stage. A substantial proportion of patients demonstrated mild-to-moderate fibrosis, while a smaller group had advanced fibrosis. Patients with obesity and diabetes had significantly higher liver stiffness values compared with those without metabolic risk factors. Elastography effectively differentiated early from advanced fibrosis stages.
Conclusion
Ultrasound elastography is a safe, rapid, and noninvasive modality for evaluating hepatic fibrosis in fatty liver disease. It provides valuable quantitative information for fibrosis staging, risk stratification, and follow-up, and may reduce the need for liver biopsy in routine clinical practice.
Zitieren
APA
Jaiswal, P., Burungale, V. A., Kast, S., Awasthi, P. K., Meena, V., & Kundu, R. K. (2026). Ultrasound Elastography in Fatty Liver Disease: A Noninvasive Assessment of Hepatic Fibrosis. Annals of African Medicine. https://doi.org/10.4103/aam.aam_526_26
Vancouver
Jaiswal P, Burungale VA, Kast S, Awasthi PK, Meena V, Kundu RK. Ultrasound Elastography in Fatty Liver Disease: A Noninvasive Assessment of Hepatic Fibrosis. Annals of African Medicine. 2026. doi:10.4103/aam.aam_526_26
BibTeX
@article{Jaiswal2026,
author = {Jaiswal, Parthvi and Burungale, Vishwajeet Arvind and Kast, Sunil and Awasthi, Puneet Kumar and Meena, Virendra and Kundu, Ravinder Kumar},
title = {Ultrasound Elastography in Fatty Liver Disease: A Noninvasive Assessment of Hepatic Fibrosis},
journal = {Annals of African Medicine},
year = {2026},
doi = {10.4103/aam.aam_526_26}
}
EUVIMED